体外几种抗菌药物对最近分离和基因分型的沙眼衣原体泌尿生殖道血清型 D 至 K 的活性。
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
机构信息
Section of Microbiology DESOS, Policlinico S. Orsola, University of Bologna, Via Massarenti 9, Bologna 40138, Italy.
出版信息
Antimicrob Agents Chemother. 2010 Dec;54(12):5379-80. doi: 10.1128/AAC.00553-10. Epub 2010 Sep 20.
Abstract
A systematic evaluation of the susceptibility of all Chlamydia trachomatis urogenital serovars (D through K) to levofloxacin, erythromycin, doxycycline, clarithromycin, and azithromycin was performed. All C. trachomatis serovars had comparable susceptibilities with respect to the various antimicrobials tested, thus confirming the homogeneous data so far obtained regarding the susceptibility of C. trachomatis to antimicrobial agents.
摘要
对所有沙眼衣原体泌尿生殖道血清型（D 至 K）对左氧氟沙星、红霉素、强力霉素、克拉霉素和阿奇霉素的敏感性进行了系统评价。所有沙眼衣原体血清型对所测试的各种抗生素均具有相似的敏感性，从而证实了迄今为止获得的关于沙眼衣原体对抗生素敏感性的同质数据。
相似文献
1
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Antimicrob Agents Chemother. 2010 Dec;54(12):5379-80. doi: 10.1128/AAC.00553-10. Epub 2010 Sep 20.
2
In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
Pathol Biol (Paris). 1993 Apr;41(4):313-5.
3
Association of the in vitro susceptibility of clinical isolates of chlamydia trachomatis with serovar and duration of antibiotic exposure.
Sex Transm Dis. 2015 Mar;42(3):115-9. doi: 10.1097/OLQ.0000000000000241.
4
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains.
Microbiol Immunol. 2000;44(4):267-9. doi: 10.1111/j.1348-0421.2000.tb02493.x.
5
Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells.
J Antimicrob Chemother. 2018 Feb 1;73(2):409-413. doi: 10.1093/jac/dkx392.
6
In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Diagn Microbiol Infect Dis. 2001 Mar;39(3):177-9. doi: 10.1016/s0732-8893(01)00221-8.
7
In vitro effects of spectinomycin and ceftriaxone alone or in combination with other antibiotics against Chlamydia trachomatis.
Antimicrob Agents Chemother. 2005 Apr;49(4):1584-6. doi: 10.1128/AAC.49.4.1584-1586.2005.
8
[Comparative study of minimal inhibiting concentrations of doxycycline, ofloxacin and erythromycin against 18 recent isolates from Chlamydia trachomatis (1994-1995)].
Pathol Biol (Paris). 1996 May;44(5):347-50.
9
[Evaluation of in vitro activity of ofloxacin against 73 strains of Chlamydia trachomatis isolated from gynecologic infections].
Pathol Biol (Paris). 1998 Feb;46(2):144-6.
10
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.
Antimicrob Agents Chemother. 2003 Mar;47(3):1135-6. doi: 10.1128/AAC.47.3.1135-1136.2003.
引用本文的文献
1
Insights into Chlamydia Development and Host Cells Response.
Microorganisms. 2024 Jun 26;12(7):1302. doi: 10.3390/microorganisms12071302.
2
The MraY Inhibitor Muraymycin D2 and Its Derivatives Induce Enlarged Cells in Obligate Intracellular and and Break the Persistence Phenotype in .
Antibiotics (Basel). 2024 May 4;13(5):421. doi: 10.3390/antibiotics13050421.
3
An NlpC/P60 protein catalyzes a key step in peptidoglycan recycling at the intersection of energy recovery, cell division and immune evasion in the intracellular pathogen Chlamydia trachomatis.
PLoS Pathog. 2023 Feb 2;19(2):e1011047. doi: 10.1371/journal.ppat.1011047. eCollection 2023 Feb.
4
Evaluating the Antibiotic Susceptibility of - New Approaches for Assays.
Front Microbiol. 2018 Jul 3;9:1414. doi: 10.3389/fmicb.2018.01414. eCollection 2018.
5
Novel Chlamydia species isolated from snakes are temperature-sensitive and exhibit decreased susceptibility to azithromycin.
Sci Rep. 2018 Apr 4;8(1):5660. doi: 10.1038/s41598-018-23897-z.
6
Selective Pressure Promotes Tetracycline Resistance of Chlamydia Suis in Fattening Pigs.
PLoS One. 2016 Nov 28;11(11):e0166917. doi: 10.1371/journal.pone.0166917. eCollection 2016.
7
Tetracycline Susceptibility in Chlamydia suis Pig Isolates.
PLoS One. 2016 Feb 25;11(2):e0149914. doi: 10.1371/journal.pone.0149914. eCollection 2016.
8
Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health.
J Pathog. 2014;2014:183167. doi: 10.1155/2014/183167. Epub 2014 Dec 31.
9
On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.
Expert Rev Anti Infect Ther. 2013 Dec;11(12):1303-32. doi: 10.1586/14787210.2013.851601. Epub 2013 Nov 6.
10
In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.
Folia Microbiol (Praha). 2013 Sep;58(5):361-5. doi: 10.1007/s12223-012-0218-2. Epub 2012 Dec 29.
本文引用的文献
1
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae.
Antimicrob Agents Chemother. 2010 Mar;54(3):1358-9. doi: 10.1128/AAC.01343-09. Epub 2009 Dec 28.
2
Clinical practice. Genital chlamydial infections.
N Engl J Med. 2003 Dec 18;349(25):2424-30. doi: 10.1056/NEJMcp030542.
3
Treatment of uncomplicated genital Chlamydia trachomatis infections in adults.
Clin Infect Dis. 2002 Oct 15;35(Suppl 2):S183-6. doi: 10.1086/342105.
4
Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
Antimicrob Agents Chemother. 2001 Nov;45(11):3001-8. doi: 10.1128/AAC.45.11.3001-3008.2001.
5
Update on Chlamydia trachomatis.
Ann N Y Acad Sci. 2000;900:293-300. doi: 10.1111/j.1749-6632.2000.tb06241.x.
6
Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp.
J Antimicrob Chemother. 1999 Jun;43(6):825-7. doi: 10.1093/jac/43.6.825.
7
Improved PCR sensitivity for direct genotyping of Chlamydia trachomatis serovars by using a nested PCR.
J Clin Microbiol. 1994 Feb;32(2):528-30. doi: 10.1128/jcm.32.2.528-530.1994.
8
1993 sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention.
MMWR Recomm Rep. 1993 Sep 24;42(RR-14):1-102.
9
Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease.
Antimicrob Agents Chemother. 1995 Mar;39(3):760-2. doi: 10.1128/AAC.39.3.760.
10
Treatment of Chlamydia trachomatis genital infection.
Rev Infect Dis. 1990 Jul-Aug;12 Suppl 6:S645-55. doi: 10.1093/clinids/12.supplement_6.s645.
Zotero 插件